KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Gsk (GSK) Revenue (2016 - 2025)

Historic Revenue for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to $11.5 billion.

  • Gsk's Revenue rose 1076.2% to $11.5 billion in Q3 2025 from the same period last year, while for Dec 2025 it was $31.7 billion, marking a year-over-year decrease of 3576.26%. This contributed to the annual value of $40.1 billion for FY2024, which is 632.11% up from last year.
  • Gsk's Revenue amounted to $11.5 billion in Q3 2025, which was up 1076.2% from $10.7 billion recorded in Q2 2025.
  • Over the past 5 years, Gsk's Revenue peaked at $33.3 billion during Q4 2021, and registered a low of $7.1 billion during Q1 2021.
  • Its 5-year average for Revenue is $12.0 billion, with a median of $9.6 billion in 2022.
  • In the last 5 years, Gsk's Revenue surged by 18849.34% in 2021 and then crashed by 5025.43% in 2022.
  • Over the past 5 years, Gsk's Revenue (Quarter) stood at $33.3 billion in 2021, then crashed by 50.25% to $16.6 billion in 2022, then rose by 5.89% to $17.5 billion in 2023, then grew by 11.59% to $19.6 billion in 2024, then plummeted by 41.08% to $11.5 billion in 2025.
  • Its Revenue was $11.5 billion in Q3 2025, compared to $10.7 billion in Q2 2025 and $9.5 billion in Q1 2025.